SI-BONE, Inc. (NASDAQ:SIBN – Get Free Report) CFO Anshul Maheshwari sold 2,418 shares of the stock in a transaction dated Friday, August 16th. The stock was sold at an average price of $13.87, for a total transaction of $33,537.66. Following the sale, the chief financial officer now directly owns 198,762 shares in the company, valued at approximately $2,756,828.94. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.
SI-BONE Stock Down 1.0 %
NASDAQ:SIBN traded down $0.14 during trading hours on Tuesday, hitting $14.18. The company’s stock had a trading volume of 234,859 shares, compared to its average volume of 400,173. SI-BONE, Inc. has a 52-week low of $11.76 and a 52-week high of $23.25. The company has a current ratio of 9.17, a quick ratio of 8.12 and a debt-to-equity ratio of 0.22. The stock has a market capitalization of $591.16 million, a P/E ratio of -13.01 and a beta of 1.20. The stock has a fifty day moving average of $14.13 and a 200-day moving average of $15.50.
SI-BONE (NASDAQ:SIBN – Get Free Report) last released its quarterly earnings data on Monday, August 5th. The company reported ($0.22) EPS for the quarter, beating analysts’ consensus estimates of ($0.26) by $0.04. The business had revenue of $39.97 million for the quarter, compared to the consensus estimate of $38.95 million. SI-BONE had a negative return on equity of 24.27% and a negative net margin of 27.10%. During the same quarter in the prior year, the business posted ($0.30) EPS. On average, equities analysts forecast that SI-BONE, Inc. will post -0.89 earnings per share for the current year.
Analyst Ratings Changes
Check Out Our Latest Analysis on SI-BONE
Institutional Trading of SI-BONE
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in SIBN. Champlain Investment Partners LLC grew its position in shares of SI-BONE by 104.8% in the 1st quarter. Champlain Investment Partners LLC now owns 2,453,147 shares of the company’s stock valued at $40,158,000 after buying an additional 1,255,610 shares during the last quarter. Bellevue Group AG grew its holdings in shares of SI-BONE by 810.5% during the first quarter. Bellevue Group AG now owns 1,139,956 shares of the company’s stock worth $18,661,000 after purchasing an additional 1,014,756 shares during the last quarter. American Century Companies Inc. increased its position in shares of SI-BONE by 22.8% during the second quarter. American Century Companies Inc. now owns 1,986,476 shares of the company’s stock worth $25,685,000 after purchasing an additional 368,637 shares in the last quarter. Victory Capital Management Inc. acquired a new stake in shares of SI-BONE during the fourth quarter worth about $6,721,000. Finally, Paradigm Capital Management Inc. NY lifted its holdings in shares of SI-BONE by 24.7% in the 2nd quarter. Paradigm Capital Management Inc. NY now owns 1,349,400 shares of the company’s stock valued at $17,448,000 after purchasing an additional 267,100 shares during the last quarter. Institutional investors and hedge funds own 98.11% of the company’s stock.
SI-BONE Company Profile
SI-BONE, Inc, a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products.
Featured Articles
- Five stocks we like better than SI-BONE
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Columbia Sportswear: A Turnaround Story That’s Gaining Ground
- 3 Warren Buffett Stocks to Buy Now
- Lowe’s Stock: Hold Now, Buy it When it Dips
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- ZIM Shipping Stock Soars as the Industry Shows a Bottoming Trend
Receive News & Ratings for SI-BONE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SI-BONE and related companies with MarketBeat.com's FREE daily email newsletter.